Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing Z Carter

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
Blood|February 3, 2005
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cellsBing Z Carter, Marcela Gronda, Zhiliang Wang, et al.
Blood Advances|August 23, 2021
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosisNaveen Pemmaraju, Bing Z Carter, Prithviraj Bose, et al.
Blood|June 20, 2023
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cellsBing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.
The Journal of Clinical Investigation|June 16, 2026
Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1Matthew Tcheng, Veronique Voisin, Geethu Emily Thomas, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
Blood|February 3, 2005
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cellsBing Z Carter, Marcela Gronda, Zhiliang Wang, et al.
Blood Advances|August 23, 2021
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosisNaveen Pemmaraju, Bing Z Carter, Prithviraj Bose, et al.
Blood|June 20, 2023
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cellsBing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.
The Journal of Clinical Investigation|June 16, 2026
Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1Matthew Tcheng, Veronique Voisin, Geethu Emily Thomas, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Pageof 8